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Background: The protein p49/STRAP (SRFBP1) is a transcription cofactor of serum response factor (SRF) which
regulates cytoskeletal and muscle-specific genes.
Results: Two conserved domains were found in the p49/STRAP protein. The SRF-binding domain was at its N-terminus
and was highly conserved among mammalian species, xenopus and zebrafish. A BUD22 domain was found at its
C-terminus in three sequence databases. The BUD22 domain was conserved among mammalian p49/STRAP
proteins, and yeast cellular morphogenesis proteins, which is involved in ribosome biogenesis that affects growth
rate and cell size. The endogenous p49/SRAP protein was localized mainly in the nucleus but also widely distributed in
the cytoplasm, and was in close proximity to the actin. Transfected GFP-p49/STRAP protein co-localized with nucleolin
within the nucleolus. Overexpression of p49/STRAP reduced actin content in cultured cells and resulted in
smaller cell size versus control cells. Increased expression of p49/STRAP in transgenic mice resulted in newborns
with malformations, which included asymmetric abdominal and thoracic cavities, and substantial changes in
cardiac morphology. p49/STRAP altered the expression of certain muscle-specific genes, including that of the
SRF gene, which is a key regulator of cardiac genes at the developmental, structural and maintenance level and
has two SRE binding sites.
Conclusions: Since p49/STRAP is a co-factor of SRF, our data suggest that p49/STRAP likely regulates cell size
and morphology through SRF target genes. The function of its BUD22 domain warrants further investigation.
The observed increase in p49/STRAP expression during cellular aging may contribute to observed morphological
changes in senescence.
Keywords: Transcription cofactor, Homology, Subcellular localization, Cell morphology, Transgenic mice, CMV
promoter reactivationBackground
The protein p49/STRAP was identified in our laboratory
in search of proteins that regulate cytoskeletal genes
related to cardiac function [1]. Our initial observations
indicated that p49/STRAP is a cofactor of serum response
factor (SRF), contributing to the regulation of SRF target
genes. This gene was later named by The Human Genome
Organization (HUGO) as SRFBP1, based on our initial
finding that p49/STRAP binds to SRF.* Correspondence: weijeanne@uams.edu
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unless otherwise stated.Serum response factor is an important transcription
factor that regulates a number of immediate-early genes,
cytoskeletal and muscle-specific genes. SRF has been
reported to exhibit functional interactions with a number
of SRF cofactors and/or binding proteins in the regulation
of SRF target genes [2-6]. These interactions likely modu-
late SRF function and may also enable SRF to mediate
tissue-specific regulation of its target genes at different
developmental stages [6,7]. A model of transcriptional
regulation by SRF and its binding proteins has been
proposed, in which the interaction of multiple proteins
(including p49/STRAP) affects the outcome of the expres-
sion of SRF target genes [1]. SRF has two functional
domains. The N-terminus is a DNA binding domain
that binds to the serum response element or CArG box
and the C-terminus is a transactivation domain [8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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transcriptional activation domain. Therefore, the level of
p49/STRAP expression and its affinity to SRF protein may
have a significant impact on SRF activation [1].
The p49/STRAP mRNA and protein are expressed in
multiple tissues, including heart, brain, liver, skeletal
muscle and kidney [1]. An increase of p49/STRAP expres-
sion has been observed in the myocardium of adult human
and mouse with advancing age, and also in transgenic
mouse models of cardiomyopathy [1,9]. However, the
functional domains of the p49/STRAP protein and the
effect of increased in-vitro and in-vivo p49/STRAP ex-
pression remain to be defined. In the present study, the
p49/STRAP protein sequence was analyzed for con-
served domains. A SRF-binding domain was found at
the N-terminus of the p49/STRAP proteins of mammals
and vertebrates; and a BUD22 domain was found at the
C-terminus of the p49/STRAP proteins and the yeast
cellular morphogenesis protein (also known as BUD22).
When p49/STRAP gene was overexpressed in cultured
cells and in transgenic mice, morphological alterations were
observed, both at the cellular and whole organ, structural
level.
Results
Bioinformatics analysis of p49/STRAP protein
The p49/STRAP protein sequences of human, mouse
and rat were analyzed using bioinformatics tools. Se-
quence alignment revealed that there was approxi-
mately 60% homology among human, mouse and rat
p49/STRAP proteins. Further sequence alignment of
13 mammalian p49/STRAP proteins, including that of
chimpanzee and dog, showed a 52% homology in p49/
STRAP proteins. Two conserved regions were found at
the N-terminus (N-region) and C-terminus (C-region)
(Figure 1A, B and Additional file 1: Figure S1). The
conserved “N-region” overlaps with the “SRF-binding
domain” that was found to interact with SRF in our
previous study [1].
The p49/STRAP protein sequences were compared
against the “Conserved Domain Database” at the National
Center for Biotechnology Information (NCBI), the “Pfam”
and the InterPro databases. The C-region of p49/STRAP
matched an existing conserved domain in all three
databases, specifically the BUD22 domain of the cellular
morphogenesis protein that regulates yeast budding
selection, polarity and RNA biogenesis (Figure 1B)
[10-12]. Each database showed a slightly different length
of BUD22 domain in p49/STRAP protein. As for the
human p49/STRAP (UniProtKB/Swiss-Prot ID: Q8NEF9),
the BUD22 domain was at amino acid 399–428 in the
NCBI Conserved Domain database; amino acid 329–428
in the Pfam database, and amino acid 360–428 in the
InterPro database, respectively.Alignment of the BUD22 sequence of 8 yeast strands
revealed that there was a conserved domain at the
C-terminus (C-region), ranging from amino acid 375 to
the end of the sequences (Additional file 1: Figure S2).
When the p49/STRAP protein sequences of 13 mam-
malian species were compared with the 8 yeast BUD22
proteins, it was found that only part of sequences at the
end of C-region, approximately 29 amino acids, was
homologous among the 21 sequences (Additional file 1:
Figure S3), indicating that those sequences represented a
highly conserved region in the BUD22 domain (Figure 1B
and Additional file 1: Figure S3).
Bioinformatics analysis indicated that there are four
NLS sequences in the human, mouse and rat p49/STRAP
proteins, while three NLS sequences were found within
BUD22 of S. cerevisiae and four NLSs in BUD22 of S.
pombe. It was also predicted that mouse p49/STRAP had
two nucleolar localization sequences (NoLS), and Baker’s
yeast BUD22 had three nucleolar localization sequences
(Figure 1C). In addition, it was also predicted that both
p49/STRAP and BUD22 proteins would be present in
the cytoplasmic compartments, including mitochondria,
endoplasmic reticulum, plasma membrane and vesicles
of the secretory system (Table 1).
Intracellular distribution of p49/STRAP
We previously observed that transfected GFP-p49/STRAP
fusion protein was mainly localized in the nucleus of
NIH3T3 cells, where it acts as a SRF cofactor to regulate
SRF-target genes [1]. Indeed, bioinformatics analysis re-
vealed that the mouse p49/STRAP had both nuclear
localization signal sequences and nucleolar localization
signal sequences (Figure 1C, E).
To confirm the bioinformatics result, H9C2 cells were
transfected with the GFP-expression control plasmid and
GFP-p49/STRAP expression plasmid, respectively. As
shown in Figure 2A and C, the green GFP fluorescence
was present in the entire cell in GFP-control plasmid
transfected cell. By contrast, in the GFP-p49/STRAP
expression plasmid transfected cells, the GFP-p49/STRAP
protein appeared to be present mainly in nucleus, with a
few very bright dots within the nucleus (Figure 2D). We
used nucleolin (a biomarker of nucleolus) to co-stain the
transfected cells. As shown in Figure 2E, nucleolin was
stained in red. When Figure 2D and E were merged
(Figure 2F), the bright green-colored GFP-p49/STRAP
dots co-localized with the red-colored nucleolin (shown
as yellow dots in merged image), indicating that the
p49/STRAP protein does localize within the nucleolus.
The p49/STRAP protein is known to be highly expressed
in multiple tissues based on Western blotting [1]. To better
understand the intracellular distribution of the endogenous
p49/STRAP protein, an affinity-purified antibody against a
p49/Strap epitope was used for immunochemistry staining
Table 1 Bioinformatic analysis of three p49/STRAP proteins and two BUD22 proteins




Protein length 429 aa 441 aa 442 519 aa 388 aa
BUD22 domain 29 aa 76 aa 82aa 411 aa 362aa
% (BUD22) 6.80% 17.20% 18.50% 85% 93%
NLS 4 4 4 3 4
ER membrane
retention signal
None None None 1 1
PTS2 1 None None 1 none
k-NN prediction 65.2% nuclear 69.6% nuclear 69.6% nuclear 73.9% nuclear 69.6% nuclear
21.7% cytoplasmic 4.3% cytoplasmic 4.3% cytoplasmic 26.1% cytoplasmic 13% cytoplasmic









4.3% mitochondrial 4.3% plasma membrane 4.3% mitochondrial 4.3% plasma membrane
4.3% Golgi 4.3% Golgi
Both p49 and BUD22 proteins were predicted to be present in the nucleus, but also in the cytoplasmic compartments, including mitochondria, endoplasmic
reticulum, plasma membrane and vesicles of the secretory system.
Figure 1 Bioinformatic analysis of p49 protein sequence. A. A schematic of the p49 protein with two conserved regions. The SRF-binding
domain is at the N-terminus; a BUD22 domain is located at the C-terminus. B. A BUD22 domain was found at the C-terminus of human, mouse
and rat p49 proteins and three yeast BUD22 proteins, based on results from the Conserved Domain Database (NCBI), Pfam and InterPro databases.
The lengths of the BUD22 domains in the six protein sequences illustrated in this diagram were based on the data from the Conserved Domain
Database. According to the Conserved Domain Database, the BUD22 domain in human p49 was 29 amino acids in length. We found that this 29
amino-acid region (between two dash lines) was highly conserved in all six protein sequences. C. A schematic of the mouse p49 protein (Unipot
ID Q9CZ91) which has four nuclear localization signal sequences (NLSs), and two nucleolar localization signal sequences (NoLSs). D. A schematic
of the BUD22 protein of Baker’s yeast (Unipot ID Q04347), which has 3 NLSs and 3 NoLSs. E. A diagram of computational prediction of nucleolar
localization signal sequence in mouse p49 protein (Unipot ID: Q9CZ91) using “NOD” (Nucleolar localization sequence Detector) website [44]. F. A
diagram of computational prediction of nucleolar localization signal sequence in BUD22 of Baker’s yeast (Unipot ID Q04347) using “NOD”
(Nucleolar localization sequence Detector) website [44].
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Figure 2 Intracellular distribution of p49/STRAP proteins. A-F: confocal microscopy revealed that p49 protein co-localized with
nucleolin within the nucleolus in H9C2 cells. A. GFP protein is distributed in both cytoplasm and nucleus in GFP control plasmid
transfected cells. B. Anti-nucleolin antibody was used to stain the nucleolus. Red fluorescence showed the nucleolus. C. Overlap of
images of A and B. D. Transfected GFP-p49 protein was mainly distributed in nucleus and concentrated as dots within the nucleus.
E. Anti-nucleolin antibody was used to stain nucleolin which is biomarker of nucleolus. Red fluorescence showed the nucleolin were
stained as red dots. F. Overlap of images D and E, revealing GFP-p49 protein (in green) and nucleolin (in red) co-localized as yellow
dots in the nucleolus. G-K: The distribution of endogenous p49 protein in H9C2 cells. The figures here revealed the abundance and the
distribution of endogenous p49 protein in cells under normal culture condition. G. The endogenous p49 protein is widely distributed in
the cell, but concentrated in the nucleus. H. Actin fiber was stained with rhodamine-phalloidin. I. Nuclei were stained with DAPI.
J. Overlap of images A, B and C, which indicated that the p49 protein was in close proximity to the actin fiber. K. Digitally enhanced
image showing that the p49 protein appeared to form a “tail” that was co-located at each end of the actin fibers, close to their
attachment sites to the inner wall of the cell membrane.
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p49/STRAP protein was present in both the nucleus and
cytoplasm. In addition, the p49/STRAP protein was
widely distributed within the cell in close proximity to
the actin fibers (Figure 2J); some of the p49/STRAP
proteins appeared to form a “tail” that was co-located
at the end of the actin fibers, close to their attachment
sites to the inner wall of the cell membrane (Figure 2J
and K). These findings suggest that p49/STRAP may play
a role in cellular cytoskeletal structure and function via its
presence in the cytoplasm.p49/STRAP overexpression affects cell morphology
To determine the effect of p49/STRAP overexpression
on cellular morphology, we infected H9C2 cells with
the GFP-control adenovirus or recombinant p49/STRAP
adenovirus [13]. At 24 hours post-infection, the cells were
fixed and immunocytochemistry staining was performed.
The phalloidin was used to stain F-actin. The p49/STRAP
antibody and Alexa Fluor 488 labelled secondary antibody
were used to stain the cells to visualize the fluorescent
intensity of both the endogenous and the exogenous
p49/STRAP proteins in the p49/STRAP-virus treated
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only in the control cells infected with GFP-control virus.
As shown in Figure 3A-D, in the GFP-control virus
infected cells, the actin fibers were present as thick, well
aligned bundles (3A, 3D and 3E), and the p49 protein
was mainly localized in the nucleus (Figure 3B, D); how-
ever, in the p49/STRAP virus treated cells, the structure
of the actin fibers was more diffuse, especially in the
perinuclear region, and the intensity of the actin fibers
was weaker (Figure 3F, I and J). Asymmetric distribution
of the p49/STRAP protein was observed within the p49/
STRAP treated cells compared to that in the control cells
(Figure 3F, H and J). Cell size measurements revealed that
H9C2 cells treated with the p49/STRAP adenovirus were
smaller (72.3 ± 0.946 SD microns) compared to that of the
control adenovirus infected cells (88.1 ± 1.41 SD microns,
Figure 4C, p < 0.05, n = 500). In addition, p49/STRAPFigure 3 p49-adenovirus treatment reduced actin contents, and alter
that were infected with GFP-control adenovirus. A. Actin fibers were well e
The green fluorescence revealed the nuclei which were stained with p49 a
were stained with DAPI. D. Overlap of the image A, B and C. E. Digitally en
contents and structure in H9C2 cells. There is fainter, less intensive visualizatio
D and E). F-J: H9C2 cells that were infected with p49-adenovirus. F. Actin fibe
green fluorescence revealed both endogenous and adenovirus delivered exo
Fluor 488 labelled secondary antibody. The p49/STRAP proteins were main
distributed within the cells (arrows). H. Nuclei were stained with DAPI. I. O
“dots”, which were a result of the merger of green and red fluorescence, w
co-localized with actin fiber (in red) within the cells. J. Digitally enhanced
contents, and altered actin fiber structure as well as cell morphology.treated cells showed much larger nucleocytoplasmic
ratios compared to that of the control, 1:10.7 ± 0.8 ver-
sus 1:30.2 ± 0.5, respectively (p < 0.01, n = 50; Figure 4A,
B and D). The overall microscopic observation revealed
that increased p49/STRAP protein reduced the F-actin
structure and intensity, and changed the cell morphology
in term of cytoskeletal structure, cell size, cell shape and
nucleocytoplasmic ratio.
p49/Strap modulated SRF gene expression
P49/STRAP is a SRF cofactor that co-regulates SRF-target
genes [1]. Since there are two SRF-binding sites (the
classic CArG boxes) in the SRF gene promoter, the SRF
gene itself is also a SRF-target gene subject to the regula-
tion by SRF [14]. To test the hypothesis that p49/STRAP
may regulate the SRF gene, a plasmid containing firefly
luciferase driven by the SRF gene promoter was used ined actin fiber structure as well as cell morphology. A-E: H9C2 cells
xpressed and well organized in control adenovirus infected cells. B.
ntibody and an Alexa Fluor 488 labelled secondary antibody. C. Nuclei
hanced image showing control virus infection did not change actin
n of the GFP protein in the cytoplasm surrounding the nucleus (Figure 3B,
r signal intensity was reduced and actin fibers were disorganized. G. The
genous p49 proteins that were stained with p49 antibody and an Alexa
ly localized in the nuclei. Part of the p49 protein was asymmetrically
verlap of the images F, G and H. The arrows pointed to the yellow
hich indicated that part of the p49 proteins (in green) were
image showing that p49-adenovirus treatment reduced actin
Figure 4 p49-adenovirus treatment reduced the actin fiber structure and intensity, and changed the cell morphology in term of
cytoskeletal structure, cell size, cell shape and nucleocytoplasmic ratio. A. Control H9C2 cells were infected with GFP-control adenovirus
and stained with Phalloidin and DAPI for visualization of F-actin and nuclei, respectively. Control cells showed relatively uniform and normal
morphology for H9C2 cell line. Nuclei occupied a small, centrally located region of the cytoplasm. Actin fibers were dense and showed uniform
network throughout the cytoplasm of the cell. B. P49/STRAP adenovirus infected H9C2 cells were stained with Phalloidin and DAPI for visualization of
F-actin and nuclei, respectively. Overexpression of p49/STRAP in H9C2 cells showed smaller overall cell size, along with less uniform cellular shape
compared to that of the control. Overall expression of actin was decreased, with significantly less uniformity among visualized fibers. Nuclei of p49/STRAP
overexpressed cells were observed to occupy a much greater percentage of the cytoplasm and peripheral location in the cell. C. Histogram of cell size
and numbers in H9C2 cell samples that were infected with p49-adenovirus versus control adenovirus. The cell size and number were measured under
microscope and multiple fields were examined. The overall cell size in p49 adenovirus-infected samples was smaller versus control adenovirus-infected
cells (n = 500, p <0.05). D. Histogram showed the nuclear to cytoplasmic ratio among control H9C2 cells infected with GFP only and adenovirus
p49/STRAP infected cells. Data indicated that overexpression of p49/STRAP resulted in a significant increase in the nuclear to cytoplasmic ratio
compared to that of the control (p < 0.05, n = 50). These results suggest that treatment with increased levels of p49/STRAP reduced cytoplasmic
volume and overall cellular morphology of H9C2 cells.
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http://www.biomedcentral.com/1471-2121/15/32the luciferase-based promoter activity assay. As shown in
Figure 5A, the SRF plasmid transfection induced SRF gene
promoter activity (p < 0.05, n = 3); when p49/STRAP
was co-transfected with SRF, p49/STRAP repressed the
SRF-induced promoter activity (p < 0.05, n = 3). Another
SRF cofactor, myocardin was also used in the transfectionassay; myocardin overexpression induced SRF gene pro-
moter activity by approximately 5-fold (P < 0.01, n = 3),
while p49/STRAP repressed the SRF-promoter activity
that was induced by myocardin plasmid transfection
(P < 0.01, n = 3). The mRNA levels of SRF and atrial
natriuretic peptide (ANF) genes were also measured in
Figure 5 p49/STRAP repressed SRF and ANF gene expression. A. Effect of p49 expression on promoter activity of SRF gene. SRF gene
promoter has two classic CArG box, therefore, SRF gene itself is regulated by SRF and SRF-cofactors. P49 had repressive effect on SRF gene
promoter activity. B. p49 repressed the mRNA expression of SRF and ANF genes. * refers to p < 0.05, n = 3; ** refers to p < 0.01, n = 3.
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http://www.biomedcentral.com/1471-2121/15/32response to p49/STRAP overexpression. As shown in
Figure 5B, p49/STRAP repressed the expression of
both the SRF gene (p < 0.05, n = 3) and the ANF gene
(p < 0.01, n = 3).
Generation of p49/STRAP transgenic mouse lines
The p49/STRAP mRNA/protein is well expressed in
multiple tissues, including brain, heart, skeletal muscle,
kidney, liver and testis [1]. To test the hypothesis that
increased expression of p49/STRAP in vivo may alter
the expression of SRF-target genes and affect the morph-
ology of mouse cells and tissues, we generated transgenic
mouse lines containing a DNA construct with p49/STRAP
cDNA under the transcriptional control of the CMV
promoter.
After multiple microinjections and screenings, three
transgenic (p49Tg) founder mice were identified. The
founder mice were bred to non-transgenic (non-Tg)
mice, and three p49Tg lines were thus established. Both
Southern blotting and quantitative PCR analysis were used
for the detection of the transgene copy number of the
three p49Tg lines. Each line was found to have only one
transgene copy.
Death of some p49/STRAP transgenic newborn mice
The p49Tg founder mice that survived to adulthood were
fertile without apparent abnormality in reproduction. The
p49Tg offspring had their genotype confirmed by PCR. An
examination of 82 litters from 6 generations of the p49Tg
mice revealed that the transgenic offspring separated into
two groups based on p49/STRAP mRNA expression
level and their phenotype (either malformed or normal-
appearing). A close check of three mouse generations
revealed that among 137 newborn p49Tg mice, 60
newborns were malformed, which accounted for 43% ofthe p49Tg offspring. The malformed group of newborn
P49Tg mice (M-p49Tg) displayed serious defects and
almost all of them were either dead at birth or died imme-
diately thereafter (Figure 6A, B). These malformed mice
had elevated level of p49/STRAP mRNA expression (by
real-time RT-PCR). The other group of newborn P49Tg
mice were grossly normal-appearing (NA-p49Tg), had no
apparent anatomic defects and most of these P49Tg mice
survived without visible abnormality. These NA-p49Tg
mice had similar levels of p49/STRAP mRNA expression
compared with that of the non-Tg mice (by real-time
RT-PCR). However, their p49/STRAP transgenic status
was confirmed by Southern blot analysis and/or by TaqMan
copy number assay.
Longitudinal sections of the dead newborn mice revealed
that the spine in the M-p49Tg newborn was shifted around
to the abdominal cavity from the back to the front (dorsal
to ventral, Figure 6C and D). Cross sections showed that
the thoracic cavity was asymmetric and the left side of the
chest was smaller than that of the right (Figure 6E and F).
Both the left and right lungs were unexpanded in the
M-p49Tg mice that were dead at birth, and the heart
morphology was substantially abnormal, without an
appropriate division and/or formation of separate cardiac
chambers in the M-p49Tg mice vs. non-Tg (Figure 6G
and H).
In the malformed M-p49Tg mice that were dead at
birth, the p49/STRAP expression was increased, while
SRF, ANF, cardiac actin, α-MHC and β-MHC were
decreased, in the whole body preparation, indicating that
p49/STRAP overexpression altered the expression of these
cardiac genes that are important in cardiac development
and cellular cytoskeletal integrity (Figure 7A) the CMV
promoter was used to drive the expression of p49/STRAP
transgene expression, the possibility of CMV promoter
Figure 6 Morphological change in p49Tg mice versus non-Tg mice. A. Image of p49Tg newborn (Tg) versus Non-Tg newborn. The arrow
indicates the p49Tg newborn missed a leg. B. The arrows highlight the contracture deformities of the limbs with additional webbing or non-delineated
appendages in the p49Tg newborn. The tissue sections from C to H were stained with H&E staining. C and D. Longitudinal section of p49Tg newborn
versus non-Tg newborn, which revealed that the spine in the M-p49Tg newborn was shifted around to the abdominal cavity from the back to the
front (dorsal to ventral). E. Cross sections of non-Tg newborn. F. Cross section of Tg newborn with asymmetric thoracic cavity. Both the left and right
lungs were unexpanded in the dead newborn the Tg mouse. G. Tissue section of non-Tg heart. H. Tissue section of p49Tg heart, which revealed
malformed heart.
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the normal-appearing mice without elevated p49/STRAP
expression. A number of reports indicate that CMV silen-
cing can be reactivated by sodium butyrate [15,16]. There-
fore, we sought to test this possibility in aortic smooth
muscle (ASM) cells that were isolated from 3 month old
Tg and NTg mice. P49/STRAP mRNA expression was
measured in response to sodium butyrate treatment. As
shown in Figure 7B, p49/STRAP mRNA level was slightly
increased after the Tg ASM cells were treated for 24 hours
in the presence of 0.5 mM sodium butyrate (p = 0.054,
n = 3). However, p49/STRAP mRNA level was increased
significantly after the Tg ASM cells were treated for 24hours in the presence of 5 mM sodium butyrate (p < 0.01,
n = 3). These findings indicate that in the present study,
CMV promoter silencing may well have repressed p49/STRAP
expression in those NA-p49Tg group, which were without ab-
normal phenotype and without increased p49/STRAP gene
expression.
Discussion
In the present study, we found that the p49/STRAP
protein has a SRF-binding domain at the N-terminus
and a BUD22 domain at the C-terminus. The N-
terminal domain containing the SRF-binding domain was
highly conserved among mammalian species, xenopus
Figure 7 Gene expression of p49 and other genes in p49Tg mouse tissue and cells versus that of non-transgenic mice. A. Gene
expression in malformed p49Tg newborns versus NTg newborns. The data indicated that p49 overexpression altered the expression of
cytoskeletal genes. * refers to p < 0.05, n = 3; ** refers to p < 0.01, n = 3. B. Aortic smooth muscle cells (isolated from 3 month old Tg and NTg)
were treated with sodium butyrate for 24 hours. P49 expression was not significant between Tg cells and NTg cells in the absence of sodium
butyrate (No treatment). There was slight increase in p49 expression Tg cells in the presence of 0.5 mM sodium butyrate, but not significant
(p = 0.054, n = 3). p49 mRNA was significantly increased in the presence of 5 mM sodium butyrate (p < 0.01, n = 3).
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BUD22 domain was conserved not only among mamma-
lian p49/STRAP proteins, but also conserved among yeast
cellular morphogenesis proteins that regulate cell morph-
ology and polarity. In addition, overexpression of p49/
STRAP in vitro and in vivo indeed changed the cell actin
content, cell size and cell polarity.
P49/STRAP is one of the SRF-binding proteins/cofac-
tors that participate in the regulation of cytoskeletal and
muscle-specific genes [1]. The SRF protein is a major tran-
scription factor in regulating cardiac, skeletal and smooth
muscle genes [17]. SRF has a DNA binding domain at the
N-terminus that binds to the SRE (CArG box) DNA se-
quence, and a transcriptional activation domain at the
C-terminus that is required for serum induction [18].
SRF and its cofactors usually form a protein complex
which binds to SRF target gene promoters and conse-
quently activates or represses the target genes [1]. There-
fore, SRF cofactors play an important role in assisting SRF
to conduct tissue-specific and development stage-specific
regulation of its target genes [1]. Among SRF cofactors,
the TCF cofactor, myocardin and MRTFs bind to the SRF
N-terminus, while p49/STRAP protein has been shown to
bind to the SRF transcriptional activation domain [1,5,17].
It has been shown that the p49/STRAP protein is usually
located within a protein complex containing the SRF and
myocardin proteins. Therefore, p49/STRAP is able to
modulate the SRF transcriptional activation [1].
The localization of p49/STRAP protein has been studied
experimentally, either through transfection assays or prote-
omic analyses [1,13,19-21]. For instance, Lamond’s grouphas reported that p49/STRAP (SRFBP1) (ID # Q96DK2, or
IPI00304493) is among a number of proteins, including
Werner syndrome helicase, Bloom’s syndrome helicase
and nucleolin, that are localized in the nucleolus [20,21].
Recently, Tafforeau et al. demonstrated that p49/STRAP
(SRFBP1) is in the nucleolus and serves as a pre-rRNA
processing factor which regulates ribosome biogenesis
[22]. The authors stated that p49/STRAP did not have a
yeast homologue [22]. However, we have now observed
that p49/STRAP does in fact, have a yeast homologue,
namely BUD22 based on the domain search in NCBI,
Pfam and InterPro databases. In addition, we observed
that p49/STRAP is localized in both the nucleus and the
nucleolus, which is similar to what has been reported
for BUD22. BUD22 is one of the proteins that regulate
yeast bud site selection and polarized cell growth in
response to both external and internal stimuli [23].
Polarized cell growth is a phenomenon that occurs in
virtually all cells and it is essential for many important
cellular events such as multicellular organ development
and cell movement.
In addition, cell size and morphology are impacted by
ribosome biogenesis which affects growth rate and cell
size [24,25]. Cell morphology is also regulated by various
BUD proteins. It has been shown that BUD22 is involved
in ribosome biogenesis, which affects both cell growth
rate and cell size [10,12]. Therefore, it is likely that p49/
STRAP may regulate cell size and morphology through
its partnership with SRF in regulating cytoskeletal genes,
and may also regulate cell morphology and polarity with
its BUD22 domain.
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ponents of cell morphology. Many of these genes are
regulated by SRF and its cofactors. In the present
study, p49/STRAP has been found to reduce actin fiber
content and change cell morphology in cultured cells.
Interestingly, the effect of p49/STRAP transfection on
reducing cellular actin correlated with reduced actin
expression in the malformed p49Tg newborns. The wide-
spread structural and especially cardiac abnormalities in
the dead newborns could be the consequence of altered
expression of important cytoskeletal genes such as actin
and other cardiac muscle-specific genes which include
α-MHC and β-MHC, ANF and SRF itself. The p49/STRAP
protein, as a co-factor of SRF, might be involved in
the regulation of cytoskeletal and muscle-specific genes
through potentially two different but related mechanisms.
First, p49/STRAP may interact with SRF protein in the
promoter of various cytoskeletal and muscle-specific
genes and modulate their expression; second, p49/STRAP
may indirectly modulate cytoskeletal and muscle-specific
genes via regulating the expression of the SRF gene itself,
which is a major regulator of many other SRF-target genes
[14,26]. The altered cellular actin dynamics may also indir-
ectly regulate SRF activation [27-29].
In the transgenic mouse lines which were created in
the present study, the p49/STRAP transgene expression
was under the control of a CMV promoter, which is
widely used to drive the ubiquitous expression of a trans-
gene. Since the transgene overexpression can sometimes
cause artifacts such as transcriptional squelching and may
change balanced gene dosage and affect downstream regu-
lation, it is also possible that the experimental results may
not reflect the real function of a transgene. This could
happen when the overexpression of a transgene is very
high [30,31]. However, in the present study, all three
p49Tg lines each has only one transgene copy, and none
of them had high transgene expression level. Therefore,
the phenotypes observed in the present study are most
likely to be the result of p49/STRAP overexpression instead
of artifacts.
The p49Tg mice appeared to separate into two differ-
ent groups, those with severe defects that died at birth,
and those without apparent defects/abnormality at
birth and continued to live in the absence of noticeable
phenotype. The main difference between these two
groups of p49Tg offspring in terms of gene expression
was in the level of p49/STRAP transgene expression: the
p49Tg with anatomical defects had elevated p49/STRAP
gene expression, while the p49Tg mice without defects
had no significant elevation in p49/STRAP expression and
their levels were similar to that of non-Tg littermates.
These findings suggest that p49/STRAP overexpression
clearly plays a critical role in the manifestation of the
abnormal phenotype observed in the p49Tg mice. Thefinding that sodium butyrate-induced reactivation of
p49/STRAP transgene mRNA expression occurred in
isolated aortic smooth muscle cells of the NA-p49Tg
mice supports the notion that CMV promoter silencing
most likely contributed to the repression of p49Tg
transgene expression in the subset of the p49Tg mice
that were without elevated p49/STRAP expression and
without abnormal phenotype [32,33].
The CMV promoter has been reported to have one
CpG island with 14 CpG sites, which are subjected to
DNA methylation or hypermethylation. Consequently,
the CMV promoter is sometimes repressed by DNA
methylation, which results in the decline, or complete
silencing of the transgene expression [15,16,32,33]. The
CMV promoter that was used in the present p49Tg
study is 654 bp long, which is part of the pcDNA3-p49/
STRAP expression plasmid [1]. The web-based software
“CPGPLOT” was used to scan the sequence [34], and a
CpG island was found in the CMV promoter that could
potentially be methylated (figure not shown), which
may have silenced the p49/STRAP transgene in some
mice. CMV promoter methylation could occur both
in vitro and in vivo [35]. The degree of repression may
vary from mouse to mouse, and may even be different
among organs within a given animal [36]. Furthermore,
the degree of CMV promoter repression could be re-
lated to the length of the promoter and the GC content
in the CMV promoter sequence which is used in the
given DNA construct; it is also related to the transgene
integration site [36].
In addition to DNA methylation, which may have oc-
curred in the CMV promoter, it is known that histone
deacetylation may also affect the CMV promoter activa-
tion [33]. Previously, we observed that overexpression
of p49/STRAP itself altered the intracellular level of
NAD, reduced the NAD/NADH ratio, and also induced
the deacetylation of the SRF protein [13]. It is therefore
plausible that overexpression of p49/STRAP itself could
also change the acetylation status of other proteins,
such as histones, and/or cause other epigenetic changes,
including CMV promoter silencing. Epigenetic stability
is important for the oocyte-to-embryo transition. Dis-
ruption of epigenetic stability could result in embryos
displaying a large variety of phenotypes and growth
defects during mouse embryogenesis [37]; perhaps
similar to what was observed in some of the malformed
p49Tg mice with elevated p49/STRAP expression.
Similar to the reversal of other epigenetic modifica-
tions, DNA methylation at the CMV promoter could
also be reversed by means of pharmacological inter-
vention. It is plausible that reversing CMV methylation
could potentially reactivate the transgene expression
[36]. Future studies to test these possibilities will be of
interest.
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Taken together, our findings indicate that p49/STRAP
participates in the regulation of cytoskeletal gene expression
and in the regulation of cell size as well as morphology/
polarity. Elevated expression of p49/STRAP in P49Tg
mice resulted in various organ defects, including asym-
metric (or polarized) distribution of the vertebral spine
and organs with altered expression of cardiac and skeletal
muscle genes. Inasmuch as p49/STRAP is a SRF binding
protein, and we have observed that it is also a homolog of
the yeast BUD22 protein (which is known to regulate cell
size and polarity), it is plausible that p49/STRAP may
serve as a bridge that links two important pathways: the
SRF-related pathway in transcriptional regulation of
cytoskeletal genes and cell size (SRF mediates PTEN’s
regulation of cell size), and the BUD22-related pathway
that regulates cell size, cell morphology and polarity.
We propose that the increased expression of p49/
STRAP that is observed in aged human and rodent cells
may mediate some of the observed changes in cellular
morphology and the appearance of some of the markers
of cellular senescence, including changes in actin structure
and other intracellular-cytoskeletal proteins. Future stud-
ies in this area will likely yield substantial information.
Methods
Bioinformatics analysis
The p49/STRAP sequences were analyzed using web-
based and/or freely-downloaded bioinformatics tools,
including “Conserved Domains” Blast [38], Pfam [39],
SMART [40,41], ExPASy [42], InterPro [43], NOD
(Nucleolar localization sequence Detector) [44], PSORT
II [45], iPSORT [46], and MultAlin [47]. The CMV pro-
moter sequence was analyzed using EMBOSS CpGPlot
software [34].
Immunocytofluorescence
For visualization of intracellular p49/STRAP and actin
fibers, H9C2 cells were equally seeded onto six-well plates
and grown in DMEM supplemented with 10% FBS at
37°C and 5% CO2 for 24 h. Upon attachment and ~80%
confluence, H9C2 cells were infected with control
adenovirus and recombinant p49/STRAP adenovirus for
24 h and 48 h, respectively. The cells were then fixed in
3.7% formaldehyde for 10 min at room temperature.
The fixative was removed by washing with PBS and cells
were permeabilized in 0.2% Triton X-100 for 5 min.
Cells were washed with PBS blocked with 3% BSA for 1
h at room temperature. Samples were then incubated
with primary rabbit p49/STRAP antibody (1:200) for 2 h
at room temperature. Fluorescent secondary antibody
signal was developed using Alexa Fluor 488 goat anti–
rabbit (1:500) for 1 h at room temperature. F-actin was
stained using rhodamine-phalloidin (1:200) for 20 min.Samples were then counterstained for 5 min with DAPI
(1:1000) to label the nuclei. Images were examined with
a 40× PLAN Fluor 1.3 objective (Nikon, Inc.) at room
temperature using an Eclipse TI inverted fluorescence
microscope (Nikon, Inc.) and captured and analyzed
with Photometrics CoolSNAP HQ2 and NIS Elements
AR software (v. 4.10.01 Nikon, Inc.). Images were exported
as TIFF files.
Affinity-purified antibody against p49/STRAP protein
As described in our previous study, we generated a
p49/STRAP antibody against a peptide (KSKKGTED
ALLKNQRRAQ) of the p49/STRAP protein, which showed
high specificity to the p49/STRAP protein [1]. In the
present study, the polyclonal antibody was commercially
purified (Genemed Synthesis Inc.) using affinity chro-
matography with the same peptide that was used for the
generation of the p49/STRAP polyclonal antibody.
Recombinant adenovirus infection
The p49/STRAP recombinant adenovirus was generated
using the AdEasy system (a generous gift from Dr.
Vogelstein, Johns Hopkins Oncology Center, MD) as
was previously reported [13].
H9C2 cells were grown in 6-well plates and infected
with control adenovirus and recombinant p49/STRAP
adenovirus for 24 h and 48 h, respectively. Adenovirus
treatment groups were performed in triplicate. After
fixation, the cells were viewed using a 20× PLAN Fluor
0.5 objective (Nikon, Inc.) at room temperature, and
the images were captured and analyzed. Post-treatment
H9C2 cell size was determined using the measurement
module in NIS Elements AR software (Nikon, Inc.). Cell
size was measured through randomized field of view
analysis for each treatment group in triplicate. For each
viral infection treatment group (Ad-EGFP and Ad-p49/
STRAP), a total of 500 cells were counted and analyzed.
The nuclear to cytoplasmic ratio was measured using
Nikon eclipse software.
Luciferase reporter assay
The plasmid DNA constructs used in the current study,
including the p49/STRAP, SRF full-length cDNA and
myocardin expression vectors, as well as the SRF gene
promoter-luciferase vector, have been previously de-
scribed [1,48].
Transient transfections were performed using Lipo-
fectamine 2000 (Invitrogen, Carlsbad, CA) as previously
described [1,9].
Generation of CMV-p49/STRAP transgenic mouse lines
The plasmid pcDNA3-p49/STRAP containing the mouse
p49/STRAP cDNA (accession # AY611629) was constructed
as previously described [1]. Briefly, to make a transgenic
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promoter, the mouse p49/STRAP cDNA and the BGH
polyadenylation signal sequence was released from the
plasmid pcDNA3-p49/STRAP using NruI and DraIII
restriction enzymes, and was separated on a low melt-
ing gel and then isolated and purified as previously
described [9,49].
The microinjection of the DNA construct and gener-
ation of the transgenic mouse line were conducted at the
Genetically Engineered Mouse Models (GEMM) Core of
the University of Arizona. Three p49/STRAP transgenic
(p49Tg) lines were generated. The TaqMan copy number
assay was used for the determination of transgene copy
number. The target gene was p49/STRAP (assay ID:
Mm00488691) and the reference gene was Tfrc (Life
technology). Southern blot analysis was also employed
for the determination of the transgene copy number
using the method previously described [9]. In all experi-
ments, age and sex-matched non-transgenic littermates
were used for comparison with the p49Tg mice. For each
time point, there were three independent biological
replicates. The studies were conducted with the approval
of the Institutional Animal Care and Use Committee
(IACUC) at Central Arkansas Veterans Healthcare System
(IACUC# 4-02-03) and in accordance with the NIH
Guiding Principles for Research Involving Animals and
Human Beings.
Histological analysis
The bodies of stillborn mice and various tissue samples
from euthanized newborn or stillborn mice were placed
in 10% neutral buffered formalin overnight. After fixation,
the samples were subjected to a dehydration series and
embedded in paraffin. Sections (3–4 uM) were stained
using standard hematoxylin and eosin (HE) or Masson
trichrome staining protocols [9].
The histological images of the stained sections were
obtained by scanning the microscope slides using a
ScanScope Digital Slide Scanner at the magnification
40× (Aperio, Vista, CA).
Real-time RT-PCR
All RNA samples were isolated from mouse tissues using
the miRNeasy Mini kit and RNase-free DNase I (Qiagen)
[50,51]. The RT-PCR was carried out using reagents
purchased from Applied Biosystems. The real-time RT-
PCR was performed using the following primers: 1)
p49/STRAP forward, 5′-gaggctttgagagtgtgaagca-3′ and
reverse, 5′-cttcccaggacggatgca-3′; 2) SRF forward, 5′-ac
cccaccacagaccagaga-3′ and reverse, 5′-ggtaggtgagatctggctc
ttca-3′; 3) ANF forward, 5′-tgggacccctccgatagatc-3′ and
reverse, 5′-agcgagcagagccctcagt-3′; 4) α-MHC forward,
5′-tggtccacattcttcaggatt-3′and reverse, 5′-cctctaggcgttcctt
ctctg-3′; 5) β-MHC forward, 5′-tcctgctgtttccttacttgc-3′and reverse, 5′-ctgagccttggattctcaaac-3′; 6) cardiac actin
forward, 5′-gctttggtgtgtgacaatgg-3′ and reverse, 5′-ctgtc
ccatacccaccatga-3′. The 5S RNA reference primers
(Exiqon) that were used as endogenous control.
The PCR amplification was performed in a StepOnePlus
Real-Time PCR System (Applied Biosystems). Relative
expression values were obtained by normalizing CT
values of the mRNA genes in comparison with CT
values of the endogenous control (5S RNA) using the
CT method [50,52].
Isolation of mouse aortic smooth muscle cells and sodium
butyrate treatment
All studies were conducted with IACUC approval. Fol-
lowing euthanasia as per approved protocol, the mouse
aortic smooth muscle (ASM) cells were isolated from
both normal-appealing p49Tg and their non-Tg litter-
mate mice according to the method described by Ray
et al. [53]. Subsequently, the ASM cells were cultured
in DMEM medium containing 15% fetal bovine serum,
100U/ml Penicillin, 100 ug/ml Streptomycin and 2.5
ug/ml Fungizone (Invitrogen). For treatment, the ASM
cells were cultured in 6-well plates in the presence of
sodium butyrate at 0.5 mM and 5 mM final concentration
for 24 hours. The ASM cells cultured in the absence of so-
dium butyrate on the same plates were used as controls.
After treatment, the cell in each well was washed with
PBS and then subjected to total RNA isolation procedure
using the miRNeasy Mini kit and RNase-free DNase I
(Qiagen) [50,51].
Statistical analysis
Data were analyzed by two independent observers,
who were blind to the transgenic status of the mice. A
two-tailed T-test was used to determine the differences
between the two groups. Bonferroni correction was
applied to multiple comparisons. A P value of <0.05
was considered to be statistically significant.
Additional file
Additional file 1: Figure S1, S2 and S3. Bioinformatics analysis of
p49/STRAP protein and search results of sequence databases.
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